Abiomed, Inc. (ABMD) Post Q1 GAAP Loss of $0.04/Share; Reaffirms Rev Outlook
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Revenue Growth %: -100.0%
Financial Fact:
Loss from operations: 14.51M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -100.0%
Financial Fact:
Loss from operations: 14.51M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Abiomed, Inc. (NASDAQ: ABMD) reported Q1 GAAP EPS of ($0.04), which may note compare to the analyst estimate of $0.06. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $42.93 million.
Abiomed, Inc. sees FY2013 revenue of $180-185 million, versus the consensus of $183.8 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Abiomed, Inc. sees FY2013 revenue of $180-185 million, versus the consensus of $183.8 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- 'A moment of truth' for Tesla and Musk is here - Wedbush
- Parke Bancorp (PKBK) Reports Q1 EPS of $0.51
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
